KR880001693A - 신규의 18- 페닐오 에스트란 유도체 - Google Patents
신규의 18- 페닐오 에스트란 유도체 Download PDFInfo
- Publication number
- KR880001693A KR880001693A KR1019870007839A KR870007839A KR880001693A KR 880001693 A KR880001693 A KR 880001693A KR 1019870007839 A KR1019870007839 A KR 1019870007839A KR 870007839 A KR870007839 A KR 870007839A KR 880001693 A KR880001693 A KR 880001693A
- Authority
- KR
- South Korea
- Prior art keywords
- steroid
- group
- oxygen
- carbon atoms
- optionally
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (6)
- 하기식을 갖는 오에스트란게의 신규한 18-페닐 스테로이드여기에서 R1과 R2는 각각 H또는 (1-4c)탄화수소 래디칼을 나타내거나, 함께 (2-6c)탄화수소 래디칼을 나타내며, R3는 H또는 임의로 하이드록실 치환체를 갖는 (1-4c) 탄화수소 래디칼을 나타내며, R4는 하이드록실기 또는 에스테르 또는 에트르기, 또는 R3와 함께 산소 또는 산소를 포함하는 헤테로고리 환 시스템을 나타내며, 점선은 기본구조의 9위치와 10위치의 탄소원자 사이에 임의로 이중결합이 존재함을 나타냄.
- 제1항에서 있어서, R3가 임의의 하이드록시 치환체를 갖는 (2-3c) 탄화수소기이며, R4가 하이드록실기인 것을 특징으로 하는 스테로이드.
- 제1항 또는 제2항에 있어서, R1이 1-3개의 탄소 원자를 포함하는 포화된 알킬기인것을 특징으로 하는 스테로이드.
- 제1항, 제2항, 제3항중 어느 한 항에 있어서, R2가 탄소수 1-3개를 포함하는 포화된 알킬기인 것을 특징으로 하는 스테로이드.
- 스테로이드 기본구조상의 위치 3 및 임의로 위치 17에 보호된 케톤기를 갖는 상응하는 화합물이 비보호 되며, 17β-하이드록실기가 에스테르화 되거나, 또는 에테르화 되거나 17-산소기가 산소를 포함하는 헤테로 고리 환 시스템을 전환되는 것을 특징으로 하는 제1항 내지 제4항에 의한 화합물을 제조하는 방법.
- 제1항에 의한 화합물중 최소한 한종류를 활성 성분으로 포함하고 있는 임신 종료 또는 임신-억제활성을 갖는 약학적 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8601903 | 1986-07-23 | ||
NL8601903 | 1986-07-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880001693A true KR880001693A (ko) | 1988-04-26 |
Family
ID=19848343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870007839A KR880001693A (ko) | 1986-07-23 | 1987-07-20 | 신규의 18- 페닐오 에스트란 유도체 |
Country Status (15)
Country | Link |
---|---|
US (1) | US4808710A (ko) |
EP (1) | EP0254341B1 (ko) |
JP (1) | JPS6335595A (ko) |
KR (1) | KR880001693A (ko) |
CN (1) | CN87106126A (ko) |
AU (1) | AU598836B2 (ko) |
CA (1) | CA1284318C (ko) |
DE (1) | DE3761308D1 (ko) |
DK (1) | DK383887A (ko) |
ES (1) | ES2015047B3 (ko) |
FI (1) | FI84274C (ko) |
GR (1) | GR3001005T3 (ko) |
NZ (1) | NZ221019A (ko) |
PT (1) | PT85395B (ko) |
ZA (1) | ZA874863B (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4992485A (en) * | 1988-10-11 | 1991-02-12 | The Dow Chemical Company | Microporous peek membranes and the preparation thereof |
DE3921059A1 (de) * | 1989-06-23 | 1991-01-10 | Schering Ag | 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel |
ZA929315B (en) * | 1991-12-20 | 1993-05-24 | Akzo Nv | 17-spirofuran-3'-ylidene steroids. |
AU710139B2 (en) * | 1996-05-01 | 1999-09-16 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | 21-substituted progesterone derivatives as new antiprogestational agents |
US6900193B1 (en) * | 1996-05-01 | 2005-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
AU2004217988C1 (en) * | 2003-02-28 | 2010-06-03 | Southwest Foundation For Biomedical Research | Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
WO2005066194A1 (en) * | 2004-01-07 | 2005-07-21 | Endorecherche, Inc. | Helix 12 directed steroidal pharmaceutical products |
US7709516B2 (en) | 2005-06-17 | 2010-05-04 | Endorecherche, Inc. | Helix 12 directed non-steroidal antiandrogens |
EP2576582B1 (en) | 2010-05-26 | 2019-09-18 | Corcept Therapeutics, Inc. | Treatment of muscular dystrophy |
EP3265127B1 (en) | 2015-03-02 | 2024-02-21 | Corcept Therapeutics, Inc. | Mifepristone and octreotide for use in the treatment of cushing's syndrome in a patient having an adrenocorticotropic hormone (acth)-secreting pancreatic neuroendocrine tumor |
AU2016243625B2 (en) | 2015-03-30 | 2020-09-10 | Corcept Therapeutics, Inc. | Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency |
CA2994422A1 (en) | 2015-08-13 | 2017-02-16 | Corcept Therapeutics, Inc. | Method for differentially diagnosing acth-dependent cushing's syndrome |
ES2861524T3 (es) | 2016-01-19 | 2021-10-06 | Corcept Therapeutics Inc | Diagnóstico diferencial del Síndrome de Cushing Ectópico |
CA3065555A1 (en) | 2017-06-20 | 2018-12-27 | Corcept Therapeutics, Inc. | Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators |
EP4263807A2 (en) | 2020-12-18 | 2023-10-25 | Instil Bio (Uk) Limited | Processing of tumor infiltrating lymphocytes |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1255345A (en) * | 1916-05-20 | 1918-02-05 | Arthur L Shaw | Conveyer. |
US3100204A (en) * | 1960-04-20 | 1963-08-06 | Merck & Co Inc | Haloethisterone compounds |
US3074978A (en) * | 1961-01-11 | 1963-01-22 | Roussel Uclaf | Process for the preparation of 13beta-n-propyl-delta4-gonene-17beta-ol-3-one and the intermediates in the preparation thereof |
US3177205A (en) * | 1963-03-01 | 1965-04-06 | Syntex Corp | 19-lower-alkyl-10alpha-derivatives of cortical hormones |
JPS4118820Y1 (ko) * | 1965-09-22 | 1966-09-02 | ||
BE697838A (ko) * | 1966-11-11 | 1967-10-02 | ||
US3725439A (en) * | 1971-01-07 | 1973-04-03 | Merck & Co Inc | 13-carbocyclic-3-keto-4-gonenes |
US4167517A (en) * | 1976-06-14 | 1979-09-11 | Veb Jenapharm | Gona-4,9(10)-dienes and process of producing the same |
ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
-
1987
- 1987-07-02 DE DE8787201258T patent/DE3761308D1/de not_active Expired - Fee Related
- 1987-07-02 EP EP87201258A patent/EP0254341B1/en not_active Expired - Lifetime
- 1987-07-02 ES ES87201258T patent/ES2015047B3/es not_active Expired - Lifetime
- 1987-07-03 ZA ZA874863A patent/ZA874863B/xx unknown
- 1987-07-09 CA CA000541648A patent/CA1284318C/en not_active Expired - Fee Related
- 1987-07-09 NZ NZ221019A patent/NZ221019A/xx unknown
- 1987-07-16 US US07/074,442 patent/US4808710A/en not_active Expired - Fee Related
- 1987-07-20 FI FI873193A patent/FI84274C/fi not_active IP Right Cessation
- 1987-07-20 KR KR1019870007839A patent/KR880001693A/ko not_active Application Discontinuation
- 1987-07-21 AU AU75969/87A patent/AU598836B2/en not_active Ceased
- 1987-07-21 JP JP62182094A patent/JPS6335595A/ja active Pending
- 1987-07-22 CN CN198787106126A patent/CN87106126A/zh active Pending
- 1987-07-22 DK DK383887A patent/DK383887A/da not_active Application Discontinuation
- 1987-07-23 PT PT85395A patent/PT85395B/pt not_active IP Right Cessation
-
1990
- 1990-04-02 GR GR90400191T patent/GR3001005T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK383887D0 (da) | 1987-07-22 |
NZ221019A (en) | 1989-12-21 |
ES2015047B3 (es) | 1990-08-01 |
US4808710A (en) | 1989-02-28 |
JPS6335595A (ja) | 1988-02-16 |
CA1284318C (en) | 1991-05-21 |
AU598836B2 (en) | 1990-07-05 |
DE3761308D1 (de) | 1990-02-08 |
EP0254341B1 (en) | 1990-01-03 |
FI84274C (fi) | 1991-11-11 |
FI873193A0 (fi) | 1987-07-20 |
FI873193A (fi) | 1988-01-24 |
EP0254341A1 (en) | 1988-01-27 |
CN87106126A (zh) | 1988-05-11 |
FI84274B (fi) | 1991-07-31 |
PT85395B (pt) | 1990-04-30 |
DK383887A (da) | 1988-01-24 |
ZA874863B (en) | 1988-01-13 |
PT85395A (en) | 1987-08-01 |
AU7596987A (en) | 1988-01-28 |
GR3001005T3 (en) | 1991-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880001693A (ko) | 신규의 18- 페닐오 에스트란 유도체 | |
KR880009036A (ko) | 신규 ii-아릴 스테로이드 유도체 | |
KR950701640A (ko) | 에리트로마이신 유도체(eryhromycin derivative) | |
KR850001691A (ko) | 디하이드로피리딘 a 화합물의 속효성 고형제제의 제조방법 | |
KR927003493A (ko) | 이리도이드 유도체 및 그의 의약으로서의 사용 | |
SE8602738D0 (sv) | Gasoline composition | |
KR890009968A (ko) | 신규의 11-아릴스테로이드 화합물 | |
KR920701162A (ko) | 퀴놀린 유도체, 당해 유도체를 함유하는 항궤양제 및 당해 유도체의 제조방법 | |
KR930007882A (ko) | 세포독성 비시클로[7.3.1]트리데 - 4 - 센 - 2,6디인 화합물 및 그의 제조방법 | |
KR830007562A (ko) | 퀴놀린 카르복실산 유도체의 제조방법 | |
KR890014107A (ko) | 백금 화학 요법약제 | |
KR900007415A (ko) | 기억장해 개선약 | |
KR920700656A (ko) | 과유지질혈증 및/또는 아테롬성 동맥경화증 처리약물 | |
KR840005116A (ko) | 옥사졸초산 유도체의 제조방법 | |
KR920701220A (ko) | 신규의 복핵 백금 착체 및 이를 유효성분으로하는 항종양제 | |
KR840008342A (ko) | 모르포린 유도체의 제조방법 | |
KR890008134A (ko) | 브라씨노스테로이드 유도체 및 식물 성장 조절제 | |
KR920702685A (ko) | 4,6-o- 히드록시포스포릴글루코사민 유도체 | |
KR890008148A (ko) | 새로운 세파로스포린 화합물 및 항균제 | |
KR840005427A (ko) | 카르보스티릴 유도체의 제조방법 | |
KR960700258A (ko) | 5-0-데소사미닐에리쓰로노라이드 유도체 | |
KR830007693A (ko) | 7-아미노 세펨 화합물을 제조하는 개량방법 | |
KR870010070A (ko) | 모라노린 유도체의 제조법 | |
KR930021653A (ko) | 단일 4차 2, 16-비스피페리디닐안드로스탄 유도체 | |
KR920002497A (ko) | 스테롤 화합물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |